GCB-DLBCL is further characterized by the phosphatase and tensin homolog (PTEN) downregulation and phosphatidylinositol-3-kinase (PI3K) upregulation, thus intensifying the PI3K signaling pathway. The gene discussed is PIK3CA; the disease is diffuse large B-cell lymphoma.